-Newsclick.in Activists have questioned the process of terming individuals as ‘doubtful’, alleging that some people are simply framed Social and psychological trauma and mental and emotional insecurity are reportedly on the rise in many parts of the rural as well as the urban Assam where updating of the National Register of Citizens (NRC) is going on a war footing in order to publish its second and final draft by July 30. Authorities...

-Livemint.com After being on the sidelines of Dalit and feminist movements for long, Dalit women are now standing up for their rights New Delhi: In 2008, seven women, aged 19-24, walked into a police station in Haryana’s Indri village in Kurukshetra district. Dressed in salwar-kameez with dupattas draped around their necks, they looked tired but confident, angry and brimming with questions. They wanted to meet the SHO and ask why no FIR...

-The Indian Express Rising cases of leprosy among Adivasis call for urgent public action. India officially eliminated Leprosy in 2005 by bringing the Prevalence Rate below 1/10000 at the national level. However, the National Health Policy 2017 (NHP), which will guide the health policy direction of the country over the next decade or so, still has elimination of Leprosy as a national level target. It is highly unlikely that India achieves elimination...

-Hindustan Times Apart from the deaths in Delhi, the study also showed that Mumbai, which was one of five megacities considered from India, reported the fourth highest number of deaths among 12 megacities. New Delhi: Close to 15,000 people died prematurely in Delhi in 2016 from illnesses linked to fine particulate matter pollution, according to a new study by researchers from India, Singapore and Thailand that assessed pollution-related deaths in 13 megacities...

-The Telegraph New Delhi: Patients' rights advocates in India on Tuesday filed two oppositions in the Indian patent office, challenging patent claims by the US pharmaceutical company Gilead Sciences for its medicines sofosbuvir and velpatasvir, used to treat hepatitis-C infections. The oppositions filed by the Delhi Network of Positive People (DNP+) challenge Gilead's patent applications for the tablet formulations of the fixed dose combination of sofosbuvir and velpatasvir and a new form...